1315282-33-7

Upstream product

• 256469-63-3 (1S,5R)-1-(hydroxymethyl)-3-oxa-bicyclo[3.1.0]hexan-2-one 
• 145032-58-2 ethyl (1S,5R)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate 
• 105-53-3 diethyl malonate 
• 917483-17-1 (-)-(1S)-1-[(1R,2S)-2-(tert-butyl-diphenyl-silanyloxymethyl)-2-vinylcyclopropyl]prop-2-en-1-ol 
• 917483-15-9 (1R,2S)-2-(tert-butyl-diphenyl-silanyloxymethyl)-2-vinylcyclopropanecarbaldehyde 
• 917483-14-8 (1R,2S)-[2-(tert-butyl-diphenyl-silanyloxymethyl)-2-vinylcyclopropyl]methanol 
• 917483-13-7 (1S,5R)-1-(tert-butyl-diphenyl-silanyloxymethyl)-3-oxabicyclo[3.1.0]hexan-2-ol 
• 870646-73-4 (1R,2S,5S)-5-[(2,2-dimethyl-1,1-diphenyl-1-silapropoxy)methyl]bicyclo[3.1.0]hex-3-en-2-ol 
• 2775-87-3 3-N-benzoyluracil 

Downstream Products

• 1337930-56-9 C₂₇H₃₀N₂O₃Si 

Relevant academic research and scientific papers

Synthesis of enantiomerically pure d- and l-bicyclo[3.1.0]hexenyl carbanucleosides and their antiviral evaluation

Based upon the fact that l-nucleosides have been generally known to be less cytotoxic than d-counterparts, l-bicyclo[3.1.0]hexenyl carbanucleoside derivatives with a fixed north conformation were designed and synthesized by employing a novel synthetic str